The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome

Multiple sclerosis (MS) is a clinically heterogenous disease. Currently, we cannot identify patients with more active disease who may potentially benefit from earlier interventions. Previous data from our lab identified the CXCL13 index (I(CXCL13)), a measure of intrathecal production of CXCL13, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pike, Steven C., Gilli, Francesca, Pachner, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341709/
https://www.ncbi.nlm.nih.gov/pubmed/37446228
http://dx.doi.org/10.3390/ijms241311050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341709/
https://www.ncbi.nlm.nih.gov/pubmed/37446228
http://dx.doi.org/10.3390/ijms241311050

Ejemplares similares